Quantifying the Evidence for the Risk of Metabolic Syndrome and Its Components following Androgen Deprivation Therapy for Prostate Cancer: A Meta-Analysis

BACKGROUND: No meta-analysis is yet available for the risk of metabolic syndrome (MetS) following androgen deprivation therapy (ADT) for men with prostate cancer. To summarize the evidence for the link between ADT and MetS or its components quantitatively with a meta-analysis including all studies p...

Descripción completa

Detalles Bibliográficos
Autores principales: Bosco, Cecilia, Crawley, Danielle, Adolfsson, Jan, Rudman, Sarah, Van Hemelrijck, Mieke
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4368630/
https://www.ncbi.nlm.nih.gov/pubmed/25794005
http://dx.doi.org/10.1371/journal.pone.0117344

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4368630/
https://www.ncbi.nlm.nih.gov/pubmed/25794005
http://dx.doi.org/10.1371/journal.pone.0117344

Ejemplares similares